Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
Long-term safety of azathioprine therapy in multiple sclerosis.
[Neurological manifestations of Behçet's disease.]
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Acute Disseminated Encephalomyelitis in Children and Adolescents: A Single Center Experience.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Human endogenous retrovirus-K contributes to motor neuron disease.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Erratum to: Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy.
Myelination, oligodendrocytes, and serious mental illness.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
Pages
« first
‹ previous
…
530
531
532
533
534
535
536
537
538
…
next ›
last »